Your browser doesn't support javascript.
loading
Cardio-Oncology Recommendations for Pediatric Oncology Patients: An Australian and New Zealand Delphi Consensus.
Toro, Claudia; Felmingham, Ben; Jessop, Sophie; Celermajer, David S; Kotecha, Rishi S; Govender, Dinisha; Terese Hanna, Diane Marie; O'Connor, Matthew; Manudhane, Rebecca; Ayer, Julian; O'Sullivan, John; Sullivan, Michael; Costello, Ben; La Gerche, André; Walwyn, Thomas; Horvath, Lisa; Mateos, Marion K; Fulbright, Joy; Jadhav, Mangesh; Cheung, Michael; Eisenstat, David; Elliott, David A; Conyers, Rachel.
Afiliación
  • Toro C; Cardiac Regeneration Laboratory, Murdoch Children's Research Institute, Parkville, Melbourne, Australia.
  • Felmingham B; Children's Cancer Centre, The Royal Children's Hospital, Parkville, Melbourne, Australia.
  • Jessop S; Department of Paediatrics, University of Melbourne, Parkville, Australia.
  • Celermajer DS; Cardiac Regeneration Laboratory, Murdoch Children's Research Institute, Parkville, Melbourne, Australia.
  • Kotecha RS; Children's Cancer Centre, The Royal Children's Hospital, Parkville, Melbourne, Australia.
  • Govender D; Michael Rice Centre for Haematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
  • Terese Hanna DM; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • O'Connor M; Department of Cardiology, RPA Hospital, Camperdown, New South Wales, Australia.
  • Manudhane R; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, Australia.
  • Ayer J; Leukaemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Australia.
  • O'Sullivan J; Curtin Medical School, Curtin University, Perth, Australia.
  • Sullivan M; Cancer Centre for Children, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
  • Costello B; Children's Cancer Centre, The Royal Children's Hospital, Parkville, Melbourne, Australia.
  • La Gerche A; Murdoch Children's Research Institute, Melbourne University, Parkville, Victoria, Australia.
  • Walwyn T; The Walter & Eliza Hall Institute, Parkville, Victoria, Australia.
  • Horvath L; Michael Rice Centre for Haematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
  • Mateos MK; Michael Rice Centre for Haematology and Oncology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
  • Fulbright J; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
  • Jadhav M; The Heart Centre for Children, The Sydney Children's Hospital Network Children's Hospital at Westmead, Westmead, New South Wales, Australia.
  • Cheung M; Department of Cardiology, RPA Hospital, Camperdown, New South Wales, Australia.
  • Eisenstat D; Heart Institute, Charles Perkins Centre, University of Sydney, Camperdown, New South Wales, Australia.
  • Elliott DA; Children's Cancer Centre, The Royal Children's Hospital, Parkville, Melbourne, Australia.
  • Conyers R; Department of Paediatrics, University of Melbourne, Parkville, Australia.
JACC Adv ; 1(5): 100155, 2022 Dec.
Article en En | MEDLINE | ID: mdl-38939459
ABSTRACT
Cardio-oncology is a new multidisciplinary area of expertise that seeks to pre-emptively and proactively address cardiac complications that emerge during and following cancer therapy. Modern therapies including molecular targeted therapy and immunotherapy have broadened the agents that can cause cardiac sequelae, often with complications arising within days to weeks of therapy. Several international guidelines have been developed for the acute monitoring of cardio-oncology side effects. However, none are specific to pediatrics. We have addressed this gap in the literature by undertaking a rigorous Delphi consensus approach across 11 domains of cardio-oncology care using an Australian and New Zealand expert group. The expert group consisted of pediatric and adult cardiologists and pediatric oncologists. This Delphi consensus provides an approach to perform risk and baseline assessment, screening, and follow-up, specific to the cancer therapeutic. This review is a useful tool for clinicians involved in the cardio-oncology care of pediatric oncology patients.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JACC Adv Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JACC Adv Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos